查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1566925

软体作为医疗设备市场：按部署类型、应用程式和最终用户：2024-2033 年全球机会分析和产业预测

Software as a Medical Device Market By Deployment Type , By Application By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 233 Pages | 商品交期: 2-3个工作天内

价格
简介目录

(SaMD) 软体作为医疗设备市场

2023 年，软体即医疗设备(SaMD) 市场价值为 1,950 万美元，预计 2024 年至 2033 年复合年增长率为 17.3%，到 2033 年将达到 9,620 万美元。

软体即医疗设备(SaMD) 是专为医疗用途而设计的专用软体，无需硬体医疗设备即可执行功能。 SaMD 帮助管理患者健康资料、诊断健康状况并推荐治疗方法。该软体用途广泛且易于使用，因为它可以在智慧型手机和平板电脑等通用运算平台上轻鬆存取。 SaMD 的主要特点是其独特地实现医疗目标的潜力，从而加速现代医疗保健系统的范围和效率。

远端医疗和远端患者监护的日益普及是软体即医疗设备(SaMD) 市场的关键驱动因素。此外，食品药物管理局和欧盟等多个监管机构的支持正在推动对 SaMD 的需求。为了更好地支援医疗保健提供者，整合临床决策支援系统 (CDSS) 是市场上的新兴趋势。 CDSS 功能有助于基于证据的临床决策，提高诊断准确性并优化治疗程序。

然而，将现有医疗记录和医疗保健资料整合到 SaMD 中既耗时又昂贵，阻碍了软体即医疗设备(SaMD) 市场的开拓。此外，该软体的使用必须遵守美国食品药物管理局(FDA) 的严格监管，这给 SaMD 开发人员带来了重大挑战。 FDA 监管要求包括上市前核准、严格的品质检查、上市后监督、网路安全要求以及某些软体修復和更新。所有这些要求确保了SaMD的可靠性和有效性，并防止关键医疗资料和患者记录的洩露。

分部审查

软体即医疗设备(SaMD) 市场分为部署类型、应用程式、最终用户和区域。根据部署类型，市场分为基于云端基础和本地市场。依应用分为筛检与诊断、监测与警报、慢性病管理、数位治疗等。依最终使用者划分，可分为医院/诊所、居家照护环境等。从区域来看，分析包括北美、欧洲、亚太地区和拉丁美洲地区。

主要发现

从部署类型来看，云端基础的细分市场在医疗设备软体市场中占据主导地位。

从应用来看，筛检诊断领域占有较高的市场占有率。

从最终用户来看，医院和诊所占有很高的份额。

按地区划分，北美在 SaMD医疗设备市场中收益最高。

可使用此报告进行客製化（需要额外费用和时间表）

  • 监管指引
  • 根据客户兴趣新增其他公司简介
  • 按国家或地区进行的附加分析 – 市场规模和预测
  • 公司简介的扩充列表
  • 历史市场资料
  • 主要参与者的详细资料（Excel格式，包括位置、联络资讯、供应商/供应商网路等）

目录

第一章简介

第 2 章执行摘要

第三章 市场状况

  • 市场定义和范围
  • 主要发现
    • 主要投资机会
    • 关键成功策略
  • 波特五力分析
  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会

第 4 章 软体作为医疗设备(SAMD) 市场：依部署类型

  • 市场概况
  • 云端基础
  • 本地

第 5 章 软体作为医疗设备(SAMD) 市场：依应用分类

  • 市场概况
  • 筛检和诊断
  • 监控和警报
  • 慢性病管理
  • 数位疗法
  • 其他的

第 6 章 软体作为医疗设备(SAMD) 市场：依最终使用者划分

  • 市场概况
  • 医院和诊所
  • 居家医疗
  • 其他的

第 7 章 软体即医疗设备(SAMD) 市场：依地区

  • 市场概况
  • 北美洲
    • 主要市场趋势和机会
    • 美国：软体即医疗设备(SaMD) 市场
    • 加拿大软体医疗设备(SaMD) 市场
    • 墨西哥的软体即医疗设备(SaMD) 市场
  • 欧洲
    • 主要市场趋势和机会
    • 德国软体即医疗设备(SaMD) 市场
    • 法国软体医疗设备(SaMD) 市场
    • 英国软体即医疗设备(SaMD) 市场
    • 义大利软体即医疗设备(SaMD) 市场
    • 西班牙软体即医疗设备(SaMD) 市场
    • 其他欧洲国家软体如医疗设备(SaMD) 市场
  • 亚太地区
    • 主要市场趋势和机会
    • 日本的软体即医疗设备(SaMD) 市场
    • 中国软体医疗设备（SaMD）市场
    • 印度软体医疗设备(SaMD) 市场
    • 澳洲软体医疗设备(SaMD) 市场
    • 韩国软体医疗设备(SaMD) 市场
    • 其他亚太地区软体即医疗设备(SaMD) 市场
  • 拉丁美洲/中东/非洲
    • 主要市场趋势和机会
    • 巴西的软体即医疗设备(SaMD) 市场
    • 沙乌地阿拉伯软体作为医疗设备(SaMD) 市场
    • 南非：软体即医疗设备(SaMD) 市场
    • 拉丁美洲、中东和非洲的医疗设备等其他软体 (SaMD) 市场

第八章 竞争格局

  • 介绍
  • 关键成功策略
  • 10家主要企业产品图谱
  • 竞争对手仪表板
  • 竞争热图
  • 主要企业定位（2023年）

第九章 公司简介

  • MindMaze
  • Siemens
  • Biofourmis
  • BrightInsight, Inc.
  • 4S Information Systems Ltd,
  • Viz.ai, Inc.
  • F. Hoffmann-La Roche Ltd
  • Koninklijke Philips NV,
  • Orthogonal
  • Zuhlke Engineering AG
简介目录
Product Code: A323957

(SaMD) Software as a Medical Device Market

The (SaMD) software as a medical device market was valued at $19.5 million in 2023 and is projected to reach $96.2 million by 2033, growing at a CAGR of 17.3% from 2024 to 2033.

Software as a medical device (SaMD) is dedicated software designed for medical use through which functions are performed without the requirement of a hardware medical device. SaMD aids in managing patient health data, diagnosing health conditions, and recommending treatments. The software is highly versatile and accessible as it is easily accessible on general-purpose computing platforms such as smartphones and tablets. A key characteristic of SaMD is its potential to independently accomplish medical objectives, thereby accelerating the scope and efficiency of modern healthcare systems.

Increase in the adoption of telehealth and remote patient monitoring is a major driver of the (SaMD) software as a medical device market. In addition, support from several regulatory bodies such as the Food and Drug Administration and the European Union is boosting the demand for SaMD. To improve the healthcare providers' assistance, the incorporation of Clinical Decision Support Systems (CDSS) is an emerging trend in the market. The capabilities of CDSS help in making evidence-based clinical decisions, thereby enhancing diagnostic accuracy and optimizing treatment procedures.

However, the integration of existing medical records and healthcare data into SaMD is a time-consuming and costly process, hence hampering the development of the (SaMD) software as a medical device market. Furthermore, usage of the software is subject to rigorous regulatory compliance by the U.S. Food and Drug Administration (FDA), which presents significant challenges for the SaMD developers. The regulatory requirements of FDA include premarket approval, strict quality check, post-market surveillance, cybersecurity requirements, and specific software modifications & updates. All these requirements ensure the reliability and efficacy of SaMD, thus preventing compromise with critical health data and patient records.

Segment Review

The (SaMD) software as a medical device market is segmented into deployment type, application, end user, and region. On the basis of deployment type, the market is bifurcated into cloud based and on premise. Depending on application, it is divided into screening & diagnosis, monitoring & alerting, chronic disease management, digital therapeutics, and others. As per end user, it is classified into hospitals & clinics, home care settings, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of deployment type, the cloud-based segment dominates the (SaMD) software as a medical device market.

Depending on application, the screening & diagnosis segment accounts for a high market share.

As per end user, the hospitals & clinics segment acquires a high stake in the market.

Region wise, North America is the highest revenue generator in the (SaMD) software as a medical device market.

Competition Analysis

The major players operating in the global (SaMD) software as a medical device market include MindMaze , Siemens, Biofourmis, BrightInsight, Inc., 4S Information Systems Ltd, Viz.ai, Inc., F. Hoffmann-La Roche Ltd, Koninklijke Philips N.V., Orthogonal, and Zuhlke Engineering AG. These players have adopted various key developmental strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Deployment Type

  • Cloud Based
  • On Premise

By Application

  • Screening and Diagnosis
  • Monitoring and Alerting
  • Chronic Disease Management
  • Digital Therapeutics
  • Others

By End User

  • Hospitals and Clinics
  • Home Care Settings
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • MindMaze
    • Siemens
    • Biofourmis
    • BrightInsight, Inc.
    • 4S Information Systems Ltd,
    • Viz.ai, Inc.
    • F. Hoffmann-La Roche Ltd
    • Koninklijke Philips N.V.,
    • Orthogonal
    • Zuhlke Engineering AG

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY DEPLOYMENT TYPE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Deployment Type
  • 4.2. Cloud Based
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. On Premise
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country

CHAPTER 5: SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY APPLICATION

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Application
  • 5.2. Screening And Diagnosis
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Monitoring And Alerting
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Chronic Disease Management
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country
  • 5.5. Digital Therapeutics
    • 5.5.1. Key Market Trends, Growth Factors and Opportunities
    • 5.5.2. Market Size and Forecast, By Region
    • 5.5.3. Market Share Analysis, By Country
  • 5.6. Others
    • 5.6.1. Key Market Trends, Growth Factors and Opportunities
    • 5.6.2. Market Size and Forecast, By Region
    • 5.6.3. Market Share Analysis, By Country

CHAPTER 6: SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY END USER

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By End User
  • 6.2. Hospitals And Clinics
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Home Care Settings
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Others
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country

CHAPTER 7: SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY REGION

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By Region
  • 7.2. North America
    • 7.2.1. Key Market Trends and Opportunities
    • 7.2.2. Market Size and Forecast, By Deployment Type
    • 7.2.3. Market Size and Forecast, By Application
    • 7.2.4. Market Size and Forecast, By End User
    • 7.2.5. Market Size and Forecast, By Country
    • 7.2.6. U.S. Software as a Medical Device (SaMD) Market
      • 7.2.6.1. Market Size and Forecast, By Deployment Type
      • 7.2.6.2. Market Size and Forecast, By Application
      • 7.2.6.3. Market Size and Forecast, By End User
    • 7.2.7. Canada Software as a Medical Device (SaMD) Market
      • 7.2.7.1. Market Size and Forecast, By Deployment Type
      • 7.2.7.2. Market Size and Forecast, By Application
      • 7.2.7.3. Market Size and Forecast, By End User
    • 7.2.8. Mexico Software as a Medical Device (SaMD) Market
      • 7.2.8.1. Market Size and Forecast, By Deployment Type
      • 7.2.8.2. Market Size and Forecast, By Application
      • 7.2.8.3. Market Size and Forecast, By End User
  • 7.3. Europe
    • 7.3.1. Key Market Trends and Opportunities
    • 7.3.2. Market Size and Forecast, By Deployment Type
    • 7.3.3. Market Size and Forecast, By Application
    • 7.3.4. Market Size and Forecast, By End User
    • 7.3.5. Market Size and Forecast, By Country
    • 7.3.6. Germany Software as a Medical Device (SaMD) Market
      • 7.3.6.1. Market Size and Forecast, By Deployment Type
      • 7.3.6.2. Market Size and Forecast, By Application
      • 7.3.6.3. Market Size and Forecast, By End User
    • 7.3.7. France Software as a Medical Device (SaMD) Market
      • 7.3.7.1. Market Size and Forecast, By Deployment Type
      • 7.3.7.2. Market Size and Forecast, By Application
      • 7.3.7.3. Market Size and Forecast, By End User
    • 7.3.8. UK Software as a Medical Device (SaMD) Market
      • 7.3.8.1. Market Size and Forecast, By Deployment Type
      • 7.3.8.2. Market Size and Forecast, By Application
      • 7.3.8.3. Market Size and Forecast, By End User
    • 7.3.9. Italy Software as a Medical Device (SaMD) Market
      • 7.3.9.1. Market Size and Forecast, By Deployment Type
      • 7.3.9.2. Market Size and Forecast, By Application
      • 7.3.9.3. Market Size and Forecast, By End User
    • 7.3.10. Spain Software as a Medical Device (SaMD) Market
      • 7.3.10.1. Market Size and Forecast, By Deployment Type
      • 7.3.10.2. Market Size and Forecast, By Application
      • 7.3.10.3. Market Size and Forecast, By End User
    • 7.3.11. Rest of Europe Software as a Medical Device (SaMD) Market
      • 7.3.11.1. Market Size and Forecast, By Deployment Type
      • 7.3.11.2. Market Size and Forecast, By Application
      • 7.3.11.3. Market Size and Forecast, By End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key Market Trends and Opportunities
    • 7.4.2. Market Size and Forecast, By Deployment Type
    • 7.4.3. Market Size and Forecast, By Application
    • 7.4.4. Market Size and Forecast, By End User
    • 7.4.5. Market Size and Forecast, By Country
    • 7.4.6. Japan Software as a Medical Device (SaMD) Market
      • 7.4.6.1. Market Size and Forecast, By Deployment Type
      • 7.4.6.2. Market Size and Forecast, By Application
      • 7.4.6.3. Market Size and Forecast, By End User
    • 7.4.7. China Software as a Medical Device (SaMD) Market
      • 7.4.7.1. Market Size and Forecast, By Deployment Type
      • 7.4.7.2. Market Size and Forecast, By Application
      • 7.4.7.3. Market Size and Forecast, By End User
    • 7.4.8. India Software as a Medical Device (SaMD) Market
      • 7.4.8.1. Market Size and Forecast, By Deployment Type
      • 7.4.8.2. Market Size and Forecast, By Application
      • 7.4.8.3. Market Size and Forecast, By End User
    • 7.4.9. Australia Software as a Medical Device (SaMD) Market
      • 7.4.9.1. Market Size and Forecast, By Deployment Type
      • 7.4.9.2. Market Size and Forecast, By Application
      • 7.4.9.3. Market Size and Forecast, By End User
    • 7.4.10. South Korea Software as a Medical Device (SaMD) Market
      • 7.4.10.1. Market Size and Forecast, By Deployment Type
      • 7.4.10.2. Market Size and Forecast, By Application
      • 7.4.10.3. Market Size and Forecast, By End User
    • 7.4.11. Rest of Asia-Pacific Software as a Medical Device (SaMD) Market
      • 7.4.11.1. Market Size and Forecast, By Deployment Type
      • 7.4.11.2. Market Size and Forecast, By Application
      • 7.4.11.3. Market Size and Forecast, By End User
  • 7.5. LAMEA
    • 7.5.1. Key Market Trends and Opportunities
    • 7.5.2. Market Size and Forecast, By Deployment Type
    • 7.5.3. Market Size and Forecast, By Application
    • 7.5.4. Market Size and Forecast, By End User
    • 7.5.5. Market Size and Forecast, By Country
    • 7.5.6. Brazil Software as a Medical Device (SaMD) Market
      • 7.5.6.1. Market Size and Forecast, By Deployment Type
      • 7.5.6.2. Market Size and Forecast, By Application
      • 7.5.6.3. Market Size and Forecast, By End User
    • 7.5.7. Saudi Arabia Software as a Medical Device (SaMD) Market
      • 7.5.7.1. Market Size and Forecast, By Deployment Type
      • 7.5.7.2. Market Size and Forecast, By Application
      • 7.5.7.3. Market Size and Forecast, By End User
    • 7.5.8. South Africa Software as a Medical Device (SaMD) Market
      • 7.5.8.1. Market Size and Forecast, By Deployment Type
      • 7.5.8.2. Market Size and Forecast, By Application
      • 7.5.8.3. Market Size and Forecast, By End User
    • 7.5.9. Rest of LAMEA Software as a Medical Device (SaMD) Market
      • 7.5.9.1. Market Size and Forecast, By Deployment Type
      • 7.5.9.2. Market Size and Forecast, By Application
      • 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top Winning Strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. MindMaze
    • 9.1.1. Company Overview
    • 9.1.2. Key Executives
    • 9.1.3. Company Snapshot
    • 9.1.4. Operating Business Segments
    • 9.1.5. Product Portfolio
    • 9.1.6. Business Performance
    • 9.1.7. Key Strategic Moves and Developments
  • 9.2. Siemens
    • 9.2.1. Company Overview
    • 9.2.2. Key Executives
    • 9.2.3. Company Snapshot
    • 9.2.4. Operating Business Segments
    • 9.2.5. Product Portfolio
    • 9.2.6. Business Performance
    • 9.2.7. Key Strategic Moves and Developments
  • 9.3. Biofourmis
    • 9.3.1. Company Overview
    • 9.3.2. Key Executives
    • 9.3.3. Company Snapshot
    • 9.3.4. Operating Business Segments
    • 9.3.5. Product Portfolio
    • 9.3.6. Business Performance
    • 9.3.7. Key Strategic Moves and Developments
  • 9.4. BrightInsight, Inc.
    • 9.4.1. Company Overview
    • 9.4.2. Key Executives
    • 9.4.3. Company Snapshot
    • 9.4.4. Operating Business Segments
    • 9.4.5. Product Portfolio
    • 9.4.6. Business Performance
    • 9.4.7. Key Strategic Moves and Developments
  • 9.5. 4S Information Systems Ltd,
    • 9.5.1. Company Overview
    • 9.5.2. Key Executives
    • 9.5.3. Company Snapshot
    • 9.5.4. Operating Business Segments
    • 9.5.5. Product Portfolio
    • 9.5.6. Business Performance
    • 9.5.7. Key Strategic Moves and Developments
  • 9.6. Viz.ai, Inc.
    • 9.6.1. Company Overview
    • 9.6.2. Key Executives
    • 9.6.3. Company Snapshot
    • 9.6.4. Operating Business Segments
    • 9.6.5. Product Portfolio
    • 9.6.6. Business Performance
    • 9.6.7. Key Strategic Moves and Developments
  • 9.7. F. Hoffmann-La Roche Ltd
    • 9.7.1. Company Overview
    • 9.7.2. Key Executives
    • 9.7.3. Company Snapshot
    • 9.7.4. Operating Business Segments
    • 9.7.5. Product Portfolio
    • 9.7.6. Business Performance
    • 9.7.7. Key Strategic Moves and Developments
  • 9.8. Koninklijke Philips N.V.,
    • 9.8.1. Company Overview
    • 9.8.2. Key Executives
    • 9.8.3. Company Snapshot
    • 9.8.4. Operating Business Segments
    • 9.8.5. Product Portfolio
    • 9.8.6. Business Performance
    • 9.8.7. Key Strategic Moves and Developments
  • 9.9. Orthogonal
    • 9.9.1. Company Overview
    • 9.9.2. Key Executives
    • 9.9.3. Company Snapshot
    • 9.9.4. Operating Business Segments
    • 9.9.5. Product Portfolio
    • 9.9.6. Business Performance
    • 9.9.7. Key Strategic Moves and Developments
  • 9.10. Zuhlke Engineering AG
    • 9.10.1. Company Overview
    • 9.10.2. Key Executives
    • 9.10.3. Company Snapshot
    • 9.10.4. Operating Business Segments
    • 9.10.5. Product Portfolio
    • 9.10.6. Business Performance
    • 9.10.7. Key Strategic Moves and Developments